Cargando…

Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ

In situ tumor ablation techniques, like radiotherapy, cryo- and heat-based thermal ablation are successfully applied in oncology for local destruction of tumor masses. Although diverse in technology and mechanism of inducing cell death, ablative techniques share one key feature: they generate tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Bijgaart, Renske J. E., Schuurmans, Fabian, Fütterer, Jurgen J., Verheij, Marcel, Cornelissen, Lenneke A. M., Adema, Gosse J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079760/ https://www.ncbi.nlm.nih.gov/pubmed/33936033 http://dx.doi.org/10.3389/fimmu.2021.617365

Ejemplares similares

Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2016)

Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes
por: Raaijmakers, Tonke K, et al.
Publicado: (2020)

Mechanical high-intensity focused ultrasound creates unique tumor debris enhancing dendritic cell-induced T cell activation
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2022)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

NSAIDs affect dendritic cell cytokine production
por: Raaijmakers, Tonke K., et al.
Publicado: (2022)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7
por: van Houtum, Eline J. H., et al.
Publicado: (2023)

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
por: Huang, Lanxiang, et al.
Publicado: (2022)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
por: Ramirez-Valdez, Ramiro A., et al.
Publicado: (2023)

Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2020)

Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting
por: Santoro, Francesco, et al.
Publicado: (2018)

Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse
por: Guo, Qianqian, et al.
Publicado: (2020)

Self-adjuvanting nanovaccines boost lung-resident CD4(+) T cell immune responses in BCG-primed mice
por: Files, Megan A., et al.
Publicado: (2022)

Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models
por: Boreel, Daan F., et al.
Publicado: (2023)

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
por: Nakashima, Hideyuki, et al.
Publicado: (2010)

HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost
por: Apostólico, Juliana de Souza, et al.
Publicado: (2016)

Low Intensity Focused Ultrasound (LOFU)-mediated Acoustic Immune Priming and Ablative Radiation Therapy for in situ Tumor Vaccines
por: Skalina, Karin A., et al.
Publicado: (2019)

Boosting Tumor-Specific Immunity Using PDT
por: Maeding, Nicole, et al.
Publicado: (2016)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
por: Kim, So Young, et al.
Publicado: (2017)

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
por: Hoves, Sabine, et al.
Publicado: (2018)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
por: Sersa, Gregor, et al.
Publicado: (2015)

CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity
por: Contreras-Kallens, Pamina, et al.
Publicado: (2022)

In situ immunization via non-surgical ablation to prevent local and distant tumor recurrence
por: Veenstra, Jesse J, et al.
Publicado: (2015)

IL-12 DNA Displays Efficient Adjuvant Effects Improving Immunogenicity of Ag85A in DNA Prime/MVA Boost Immunizations
por: Morelli, María Paula, et al.
Publicado: (2020)

In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
por: Guo, Yuxin, et al.
Publicado: (2022)

Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
por: Kim, Jaejo, et al.
Publicado: (2023)

Tn Antigen Expression Contributes to an Immune Suppressive Microenvironment and Drives Tumor Growth in Colorectal Cancer
por: Cornelissen, Lenneke A. M., et al.
Publicado: (2020)

A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer
por: Cornelissen, Lenneke A.M., et al.
Publicado: (2016)

More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization
por: Hwang, Hye Suk, et al.
Publicado: (2018)

Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
por: Ho, Nataschja I., et al.
Publicado: (2018)

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
por: Pan, Yuting, et al.
Publicado: (2020)

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Chapman, Ros, et al.
Publicado: (2021)

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
por: Chesson, Charles B., et al.
Publicado: (2018)

Induction of mucosal and systemic antibody and T-cell responses following prime–boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
por: Cristillo, Anthony D., et al.
Publicado: (2011)

Supporting tumor therapy by exercise: boosting T cell immunity by myokines
por: Gebhardt, Kristina, et al.
Publicado: (2022)

A promising self-nanoemulsifying adjuvant with plant-derived saponin D boosts immune response and exerts an anti-tumor effect
por: Luo, Xing, et al.
Publicado: (2023)

In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
por: Lin, Zhongda, et al.
Publicado: (2023)

Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
por: Chen, Lu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sd8b1vbc2r00o6kpcl5pvb409k